▶ 調査レポート

世界の脱毛治療製品市場2022年-2027年:成長・動向・新型コロナの影響・市場予測

• 英文タイトル:Hair Loss Treatment Products Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Hair Loss Treatment Products Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)「世界の脱毛治療製品市場2022年-2027年:成長・動向・新型コロナの影響・市場予測」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2203A566
• 出版社/出版日:Mordor Intelligence / 2022年1月
• レポート形態:英文、PDF、95ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:消費財
• 販売価格(消費税別)
  Single User¥703,000 (USD4,750)▷ お問い合わせ
  Site Licence¥962,000 (USD6,500)▷ お問い合わせ
  Corporate License¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社は、世界の脱毛治療製品市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、流通チャネル別(スーパーマーケット/ハイパーマーケット、コンビニ、専門小売業者、オンラインストア、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ)分析、競争状況、市場機会・将来の傾向などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の脱毛治療製品市場規模:流通チャネル別(スーパーマーケット/ハイパーマーケット、コンビニ、専門小売業者、オンラインストア、その他)
・世界の脱毛治療製品市場規模:地域別(北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ)
・競争状況(The Procter & Gamble Company、L'Oréal S.A.、Unilever、...)
・市場機会・将来の傾向

The global hair loss treatment products market is projected to grow at a CAGR of 3.56% during the forecast period.

Key Highlights

  • The major drivers driving the market are changing lifestyle patterns, adoption of a hectic schedule that increases stress levels, which in turn results in frequent hair loss at an earlier stage among the young population, growing disposable income and increased emphasis on appearances.
  • The presence of an alternative treatment options for hair loss such as hair transplant surgery, laser, and light-based therapies and high cost of medication is going to restrain the market in the forecast period.

Key Market Trends

Rising Concerns Regarding Hair Loss among Women

Hair loss is a critical issue among men and women across the world. Men, owing to Androgenetic Alopecia or common male pattern baldness (MPB), have been suffering from hair loss for long. However, recently, women are also experiencing increased hair loss, due to external factors, such as environmental pollution and chemicals. According to the American Academy of Dermatology, 40% of women have visible hair loss by the age of 40. In most cases, hair loss in women affects their self-image and emotional well-being. As a result, the American Hair Loss Association recognized hair loss in women to be a serious life-altering condition that cannot be ignored anymore. Hormone imbalance and diseases are the primary reasons for hair loss. In such cases, hair loss is often naturally reversed, as the subject undergoes unpredictable patterns of growth and shedding.

Asia- Pacific Dominates the Market

North America is having a huge market for hair loss medication and is going to dominate the market over the period of forecast followed by Europe. According to American Hair Loss Association more than 80 million men and women are suffering from hair loss problems in the US alone. There are many positive initiatives taken by organizations such as NAAF and the American Hair Loss Association. According to the Eurostat, the population in the European Union between 15-60 years is expected to decline by 2060, while the population above 60 years is expected to grow from 18% to 30%. Similarly, in America, the ageing population is forecasted to be doubled by 2060 to reach 98 million. Increased hair loss problems due to ageing have strongly affected the market growth.

Competitive Landscape

The hair loss treatments market is very competitive with a large number of international and regional companies fighting for the money. Both Beauty and Pharmaceutical companies are developing new formulas and product launches to keep up with the technological advancements in new product releases.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Deliverables & Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porters Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 Distribution
5.1.1 Supermarkets and Hypermarkets
5.1.2 Convenience Stores
5.1.3 Specalist Retailers
5.1.4 Pharmacies
5.1.5 Online Retail
5.1.6 Others
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.1.4 Rest of North America
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Russia
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 India
5.2.3.2 China
5.2.3.3 Australia
5.2.3.4 Japan
5.2.3.5 Rest of Asia-Pacific
5.2.4 South America
5.2.4.1 Brazil
5.2.4.2 Argentina
5.2.4.3 Rest of South America
5.2.5 Middle East
5.2.5.1 United Arab Emirates
5.2.5.2 Saudi Arabia
5.2.5.3 South Africa
5.2.5.4 Rest of Middle East and Africa

6 COMPETITIVE LANDSCAPE
6.1 Most Active Companies
6.2 Market Share Analysis
6.3 Key strategies adapted by Leading Players
6.4 Company Profiles
6.4.1 The Procter & Gamble Company
6.4.2 L’Oréal S.A.
6.4.3 Unilever
6.4.4 Taisho Pharmaceutical Co., Ltd.
6.4.5 Henkel AG & Company, KGaA
6.4.6 Merck & Co., Inc
6.4.7 Shiseido Company, Limited
6.4.8 Johnson & Johnson

7 MARKET OPPORTUNITIES AND FUTURE TRENDS